GermlineRAD51Cmutations in ovarian cancer susceptibility

Mutation analysis of RAD51D in non-BRCA1/2 ovarian and breast cancer families

(2012) D J Osher et al.   BRITISH JOURNAL OF CANCER

Germline RAD51C mutations confer susceptibility to ovarian cancer

(2012) Chey Loveday et al.   NATURE GENETICS

A HRM-based screening method detects RAD51C germ-line deleterious mutations in Spanish breast and ovarian cancer families

(2011) Atocha Romero et al.   BREAST CANCER RESEARCH AND TREATMENT

BRIP1, PALB2, and RAD51C mutation analysis reveals their relative importance as genetic susceptibility factors for breast cancer

(2011) Michelle W. Wong et al.   BREAST CANCER RESEARCH AND TREATMENT

Mutation analysis of RAD51L1 (RAD51B/REC2) in multiple-case, non-BRCA1/2 breast cancer families

(2011) Julie Johnson et al.   BREAST CANCER RESEARCH AND TREATMENT

RAD51C is a susceptibility gene for ovarian cancer

(2011) Liisa M. Pelttari et al.   HUMAN MOLECULAR GENETICS

Analysis of RAD51C germline mutations in high-risk breast and ovarian cancer families and ovarian cancer patients

(2011) Ella R. Thompson et al.   HUMAN MUTATION

Germline mutations in RAD51D confer susceptibility to ovarian cancer

(2011) Chey Loveday et al.   NATURE GENETICS

Mutations in BRIP1 confer high risk of ovarian cancer

(2011) Thorunn Rafnar et al.   NATURE GENETICS

Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing

(2011) T. Walsh et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Screening RAD51C nucleotide alterations in patients with a family history of breast and ovarian cancer

(2010) Yonglan Zheng et al.   BREAST CANCER RESEARCH AND TREATMENT

Genetic Heterogeneity in Human Disease

(2010) Jon McClellan et al.   CELL

A One-Step Prescreening for Point Mutations and Large Rearrangement in BRCA1 and BRCA2 Genes Using Quantitative Polymerase Chain Reaction and High-Resolution Melting Curve Analysis

(2010) Florence Coulet et al.   Genetic Testing and Molecular Biomarkers

Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene

(2010) Alfons Meindl et al.   NATURE GENETICS

Inhibition of Poly(ADP-Ribose) Polymerase in Tumors fromBRCAMutation Carriers

(2009) Peter C. Fong et al.   NEW ENGLAND JOURNAL OF MEDICINE